Merck Kgaa

Merck Serono pledges €150m to biosimilars in 2015

Merck Serono pledges €150m to biosimilars in 2015

By Zachary Brennan

Merck Serono is planning to invest between €130m ($168m) and €150m ($194m) in biosimilars in 2015, depending on the outcome of ongoing Phase I studies, the company announced Thursday.